MPP recently provided testimony to an FDA panel charged with re-examining dental amalgam. We pointed out that while FDA panel re-evalutates, the World Health Organization is expected to recommend that amalgam use be “phased down.” “We welcome WHO’s support for “phase down” , and urge FDA to do the same,” said MPP’s director. The WHO is expected to soon final its meeting report in preparation for the upcoming International Negotiations Committee deliberations in Chiba, Japan, 24-28 January, 2011, that will ultimately lead to the adoption of a legally binding instrument on mercury by 2013.
The European Environmental Bureau and MPP recently wrote a letter urging the World Health Organization (WHO) to correct inaccuracies, misleading and incorrect statements before finalizing its meeting report. Unfortunately, the draft report’s bias is already being diffused on various pro-amalgam websites, including one from Australia and the other from the USA. Among other things, the letter encourages WHO to correct for the record that the purpose of the meeting was to discuss alternatives to amalgam, and not debate or assert the safety of amalgam, — and instead to highlight opportunities for “phasing down” the amalgam use, as WHO discussed in Stockholm in June.